Does NELARABINE Cause Myelosuppression? 12 Reports in FDA Database

Q: Does NELARABINE cause Myelosuppression?

12 reports of Myelosuppression have been filed with the FDA for NELARABINE, representing 1.6% of all NELARABINE adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Myelosuppression have been filed in association with NELARABINE (Nelarabine). This represents 1.6% of all adverse event reports for NELARABINE.

Reports of Myelosuppression with NELARABINE

1.6%

of all NELARABINE reports

Deaths

Hospitalizations

How Dangerous Is Myelosuppression From NELARABINE?

Of the 12 reports, 5 (41.7%) required hospitalization, and 2 (16.7%) were considered life-threatening.

Is Myelosuppression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NELARABINE. However, 12 reports have been filed with the FAERS database.

What Other Side Effects Does NELARABINE Cause?

Febrile neutropenia (67) Drug ineffective (50) Myelopathy (47) Neurotoxicity (47) Neuropathy peripheral (45) Muscular weakness (42) Sepsis (39) Peripheral sensory neuropathy (38) Neutropenia (37) Off label use (37)

What Other Drugs Cause Myelosuppression?

CYCLOPHOSPHAMIDE (3,603) CARBOPLATIN (2,624) TRASTUZUMAB (2,552) PACLITAXEL (2,522) TISLELIZUMAB (2,142) CYTARABINE (1,869) VENETOCLAX (1,864) CISPLATIN (1,849) BEVACIZUMAB (1,744) SODIUM (1,696)

Which NELARABINE Alternatives Have Lower Myelosuppression Risk?

NELARABINE vs NELFINAVIR NELARABINE vs NELVUTAMIG NELARABINE vs NEMOLIZUMAB NELARABINE vs NEMOLIZUMAB-ILTO NELARABINE vs NEOMYCIN

NELARABINE Full Profile All Myelosuppression Reports All Drugs Causing Myelosuppression NELARABINE Demographics